Skip to main content

Table 1 Baseline clinical and serological characteristics of patients with RA

From: Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugs

Characteristic

Value

Demographic parameters

 Sex, F/M

23/2

 Age, mean (SD), years

59 (12.6)

 Disease duration, mean (SD), years

6.3 (8.8)

Laboratory parameters

 ESR, mean (mm/h) (SD)

17.6 (9.3)

 CRP, mean (mg/dL) (SD)

0.68 (0.65)

 RF positivity, n (%)

19 (76)

 ACPA positivity, n (%)

18 (72)

Disease activity

 TJ n, mean (SD)

5.8 (5.4)

 SJ n, mean (SD)

2.6 (2.4)

 CDAI, mean (SD)

19.3 (10.8)

 DAS28, mean (SD)

4.2 (1.6)

Therapy

 Etanercept, n (%)

20 (80)

 Adalimumab, n (%)

5 (20)

 Concurrent MTX, n (%)

13 (52)

  1. SD standard deviation, ESR Erythrocyte Sedimentation Rate, CRP C-Reactive Protein, RF Rheumatoid Factor, ACPA anti-citrullinated peptide antibodies, TJ Tender joints, SJ swollen joints, CDAI Clinical Disease Activity Index, DAS28 Disease Activity Score on 28 joints, csDMARDs conventional synthetic disease-modifying antirheumatic drugs